177 related articles for article (PubMed ID: 24374613)
1. Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG.
Vicco MH; Bontempi IA; Rodeles L; Yodice A; Marcipar IS; Bottasso O
Med Microbiol Immunol; 2014 Apr; 203(2):133-9. PubMed ID: 24374613
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
[TBL] [Abstract][Full Text] [Related]
3. β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease.
Vicco MH; Pujato N; Bontempi I; Rodeles L; Marcipar I; Bottasso OA
Can J Cardiol; 2014 Mar; 30(3):332-7. PubMed ID: 24370375
[TBL] [Abstract][Full Text] [Related]
4. Antibody profiles induced by Trypanosoma cruzi in chagasic patients with previous or current exposure to mycobacteria.
Peverengo L; Prochetto E; Rodeles L; Valenzuela I; Marcipar IS; Bottasso O; Vicco MH
Pathog Dis; 2016 Dec; 74(9):. PubMed ID: 27815312
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease.
Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS
Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response.
Araujo Z; El Bouhdidi A; Heremans H; Van Marck E; Castés M; Carlier Y
Vaccine; 1999 Feb; 17(7-8):957-64. PubMed ID: 10067703
[TBL] [Abstract][Full Text] [Related]
7. IgG Autoantibodies Induced by T. cruzi During Pregnancy: Correlation with Gravidity Complications and Early Outcome Assessment of the Newborns.
Vicco MH; Rodeles L; Capovilla GS; Perrig M; Choque AG; Marcipar I; Bottasso O; Rodriguez C; Cuña W
Matern Child Health J; 2016 Oct; 20(10):2057-64. PubMed ID: 27318490
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice.
Araujo Z; Heremans H; Stordeur P; Wissing M; Goldman M; Castes M; Carlier Y
Vaccine; 2000 Mar; 18(17):1822-9. PubMed ID: 10699330
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
[TBL] [Abstract][Full Text] [Related]
10. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
11. Role of autoantibodies in the physiopathology of Chagas' disease.
Medei EH; Nascimento JH; Pedrosa RC; Carvalho AC
Arq Bras Cardiol; 2008 Oct; 91(4):257-62, 281-6. PubMed ID: 19009179
[TBL] [Abstract][Full Text] [Related]
12. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins.
Motrán CC; Cerbán FM; Rivarola W; Iosa D; Vottero de Cima E
Exp Parasitol; 1998 Mar; 88(3):223-30. PubMed ID: 9562426
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
[TBL] [Abstract][Full Text] [Related]
15. BCG-induced resistance in Trypanosoma cruzi experimental infections.
Bertelli MS; Alcantara A; Brener Z
Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
[TBL] [Abstract][Full Text] [Related]
16. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
[TBL] [Abstract][Full Text] [Related]
17. The potential influence of atherogenic dyslipidemia on the severity of chronic Chagas heart disease.
Peverengo L; Rodeles L; Vicco MH; Marcipar I
Rev Assoc Med Bras (1992); 2016; 62(1):45-7. PubMed ID: 27008492
[TBL] [Abstract][Full Text] [Related]
18. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
19. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
Olivera V; Bizai ML; Arias E; Suasnabar S; Bottasso O; Marcipar I; Fabbro D
Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to neurotrophic receptors TrkA, TrkB and TrkC in patients with acute Chagas' disease.
Lu B; Luquetti AO; Rassi A; PereiraPerrin M
Scand J Immunol; 2010 Mar; 71(3):220-5. PubMed ID: 20415787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
